Results 161 to 166 of about 1,271 (166)

Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients

Clinical Chemistry and Laboratory Medicine, 2021
Lorenzo Ferri, Sandro Feriozzi, Renzo Mignani   +2 more
exaly  

Diagnostic Usefulness of Plasma Level of Globotriaosylsphingosine in Patients with Anderson-Fabry Disease

Journal of Cardiac Failure, 2017
Koichiro Sugimura, Saori Yamamoto, Tatsuo Aoki, Shunsuke Tatebe, Nobuhiro Yaoita, Haruka Sato, Katsuya Kozu, Ryo Konno, Kimio Satoh, Hiroaki Shimokawa   +9 more
openaire   +1 more source

Usefulness of lyso-globotriaosylsphingosine in dried blood spots in the differential diagnosis between multiple sclerosis and Anderson–Fabry's disease

Multiple Sclerosis and Related Disorders, 2020
Susana Olivera, Sebastian Menao
exaly  

Clinical Journal of the American Society of Nephrology

Clinical Journal of the American Society of Nephrology: CJASN, 2013
Jun Tohyama, Ichiei Narita, Satoshi Ishii   +2 more
exaly  

Globotriaosylsphingosine (Lyso-GB3 bzw. Lyso-GL3), an Excellent Biomarker for Children with Fabry Disease

Neuropediatrics, 2017
N. Karabul, T. Marquardt, M. Petersen, A. Beckmann, E. Namal, T. Lücke   +5 more
openaire   +1 more source

Phenotype, genotype and disease severity reflected by serum globotriaosylsphingosine Levels in patients with Fabry disease

2018
openaire   +1 more source